This shows a brain and a doctor.
Ward added that it is also possible that symptom provocation has different effects in different populations. Credit: Neuroscience News

Symptom Provocation Boosts Brain Stimulation Effectiveness

Summary: A new meta-analysis suggests that provoking symptoms just before delivering repetitive transcranial magnetic stimulation (rTMS) can improve clinical outcomes for OCD and nicotine dependence. Researchers examined data from multiple studies and found that rTMS was nearly twice as effective when paired with targeted symptom provocation.

For example, patients with OCD were asked to trigger obsessive thoughts, and those with nicotine dependence were exposed to cigarette-related cues before treatment. While not conclusive, these findings highlight a potentially valuable approach to enhancing rTMS efficacy and call for further controlled trials.

Key Facts:

  • Boosted Efficacy: rTMS was nearly twice as effective when combined with symptom provocation.
  • Targeted Triggers: Provoking obsessions or cravings before rTMS appears to activate relevant brain circuits.
  • Need for Trials: Researchers call for randomized studies to confirm effectiveness across disorders.

Source: Vanderbilt University

A new study in JAMA Psychiatry makes the case that symptom provocation may significantly improve the clinical effectiveness of repetitive transcranial magnetic stimulation (rTMS), a noninvasive brain stimulation method used to treat depression, obsessive-compulsive disorder (OCD) and nicotine dependence.

The study was conceptualized, designed and supervised by Heather Burrell Ward, MD, assistant professor of Psychiatry and Behavioral Sciences and director of Neuromodulation Research, in collaboration with Simon Vandekar, PhD, associate professor of Biostatistics and Daniel Bello and Megan Jones, two students in their respective labs.

This is the first large-scale meta-analysis to examine whether deliberately triggering symptoms immediately before administering rTMS enhances treatment outcomes.

“The FDA-approved protocols for OCD and nicotine dependence include a ‘symptom provocation’ immediately before administering rTMS,” Ward said.

“For OCD, this means provoking obsessive thoughts; so, if someone has obsessions about hygiene, you could have them put their hand in a trashcan or touch the bottom of their shoe immediately before receiving rTMS.

“For nicotine dependence, this involves provoking nicotine craving, so you can have someone imaging smoking a cigarette, or even take out one of their own cigarettes, hold it in their hand, and even smell it.

“There is some evidence to suggest that activating a brain circuit immediately before applying rTMS will make the rTMS more effective. However, this evidence has been from small studies and has never been analyzed in large numbers to draw definitive conclusions.

“We therefore performed a systematic review with meta-analysis, a study that combines results from many previous studies, to investigate the effects of symptom provocation on clinical response to rTMS for OCD and nicotine dependence.

“Meta-analyses are important because they summarize results across all studies to provide a more reliable estimate of an effect than any single study alone.”

In the entire analysis, symptom provocation did not significantly improve clinical response — which is often measured by reduction in OCD symptoms or cigarette use.

However, rTMS was nearly twice as effective when symptom provocation was used compared to when it was not used, which suggests that symptom provocation may enhance response to rTMS.

“It was surprising to see that symptom provocation seemed to enhance clinical response for both OCD and nicotine dependence, despite different rTMS protocols, targets and provocation methods,” Ward said.

Ward added that it is also possible that symptom provocation has different effects in different populations.

“For example, some studies suggest that, in contrast to the general population, people with schizophrenia do not crave cigarettes upon being presented with smoking-related images,” she said.

“In that case, perhaps symptom provocation would not be appropriate for rTMS for nicotine dependence in schizophrenia.”

Ward, who is currently principal investigator of a clinical trial comparing rTMS interventions for nicotine use in people with and without schizophrenia, sees these as important questions to address in the future.

“While this meta-analysis is incredibly valuable to the field in suggesting that symptom provocation may enhance clinical response to rTMS, it is critical that prospective, randomized, controlled studies are performed that directly test if symptom provocation improves response to rTMS,” she said.

“These should be conducted for OCD and nicotine dependence as well as other disorders, including other substance use disorders, and other rTMS targets. Perhaps there are some brain circuits that need to be activated immediately prior to modulation and others that do not. Interestingly, when rTMS is used to treat depression, we do not provoke depressive symptoms.

“As a psychiatrist who administers rTMS in clinical and research settings, I want to know exactly what I need to do to make rTMS as effective as possible for my patients. There is so much left for us to learn about ways to optimize rTMS treatment, and Vanderbilt is a leader in that field.”

About this rTMS brain stimulation research news

Author: Craig Boerner
Source: Vanderbilt University
Contact: Craig Boerner – Vanderbilt University
Image: The image is credited to Neuroscience News

Original Research: Closed access.
Symptom Provocation and Clinical Response to Transcranial Magnetic Stimulation” by Heather Burrell Ward et al. JAMA Psychiatry


Abstract

Symptom Provocation and Clinical Response to Transcranial Magnetic Stimulation

Importance  

Transcranial magnetic stimulation (TMS), a form of noninvasive brain stimulation used to treat major depressive disorder, obsessive-compulsive disorder (OCD), and nicotine dependence, has well-established state-dependent effects on brain circuitry. However, a major question for TMS remains: does brain state affect clinical response?

Objective  

To quantify the association between symptom provocation and clinical response to TMS for OCD and nicotine dependence, the only Food and Drug Administration–cleared TMS indications with symptom provocation.

Data Sources  

PubMed, CINAHL, Embase, PsycInfo until August 30, 2024.

Study Selection  

Randomized clinical trials of TMS for OCD or nicotine dependence with a clinical outcome. Of 600 studies identified, 71 met inclusion criteria.

Data Extraction and Synthesis  

Data extraction was completed independently by 2 extractors and cross-checked by a third. Standardized mean difference (SMD) and SE were estimated via Hedges g and synthesized data in a 3-level random-effects meta-analysis. Study data were analyzed from August 2023 to March 2025.

Main Outcomes and Measures  

Primary outcomes were clinical response measures.

Results  

A total of 71 studies met inclusion criteria and included 3246 participants (mean [SD] age; 37.8 [8.0] years; mean [SD] percentage female, 44.1% [17.2%]). Included in the meta-analysis were 63 studies with 2998 participants. For OCD studies, active TMS was associated with better clinical response than sham both with (SMD = −0.51; 95% CI, −0.96 to −0.07; P = 0.04) and without (SMD = −0.29; 95% CI, −0.40 to −0.17; P < .001) symptom provocation.

For nicotine use, active TMS was associated with better clinical response than sham when used with (SMD = −0.56; 95% CI, −1.12 to 0; P = .05) but not without (SMD = −0.35; 95% CI, −0.74 to 0.04; P = .08) symptom provocation. For OCD studies, the estimated expected added effect of provocation was SMD of −0.22 (95% CI, −0.65 to 0.20; P = .22). In nicotine studies, the estimated expected added effect of provocation was SMD of −0.21 (95% CI, −1.00 to 0.58; P = .57).

Conclusions and Relevance  

Results of this systematic review and meta-analysis suggest that symptom provocation may enhance clinical response to TMS for OCD and nicotine dependence. Studies comparing TMS with and without provocation are critical to establish the causal effect of provocation.

Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.
  1. I am a different and new kind of Neuroscientist. I have placed good suggestions in to University Of Florida. I am against rTCM stimulation because I know that our nerves in our brain really want to attach and make for more regeneration and to heal up. I have discovered a method on my own that really works, and combats the most wrong anxiety that would come at a person, to maintaining control under pressure that is really big by practicing a focus meditation called Brim Psychosa and it focuses on self love, for self confidence, and it harmonizes with people who want to be trained to recover from addiction. I myself quit smoking and I have lost 40 pounds in 4 months, and still losing weight, and I am doing good today, in the best mind set and focused on improving and I understand concepts of behavior that would lead even a mouse to performing some act that would prove that it is best for neuron health. I feel more stable mentally, and I have improved greatly am able to combat anxiety in a resilient way, and I am usually stress free, and I noticed that I have joint pain relief as I sleep. I perform exercises that are training my muscle groups to improve their tissue health and nerve health. I still need a heart transplant because I have a weakened heart, and I still need my brain lesions to be removed, and I still need to get new legs because my knees are damaged and I have dystonia in my left leg and cramping in it from being given antipsychotics, SSRi’s and agents that are said to help hormones function. I have learned that one has got to care about themselves to be able to perform good work. I had the thought that eventually I could be a surgeon to repair a person’s nerve damage. I have a working theory on blood and I posted it on LinkedIn. I’d like to get a Bachelor’s degree in Neuroscience to focus on blood and nerve damage repair. I myself was repaired a lot in life especially after the shark attacks and I learned excellent physical therapy techniques to empower me. I am a highly empowering person that is good at making a hole in one, but not at basketball. I have vertigo and epilepsy and both have improved in one week of taking a specific kind of diet that I ate and drank. Talking to people helps most of all. I disagree with rTCM because it is said that neurons that wire together, fire together. I have been through extensive damage in life, and am stable and maintaining, and I think that gaining the health benefits from the blue whale sperm will help to heal brain damage and past aneurysms and stroke. Forgiving an enemy is difficult, but to just start healing is the way that can help to shape behavior. Behavior shaping is what I’m good at, and my practice does not include to bother rats or mice. I would be interested in using the power of the swift momentum of how the gorilla travels to tell all that tiger teeth are sharp and they want to eat a man if they are not tamed. I know for a fact that animals can save human lives. I’m living proof. Even a mouse can learn to cooperate to bring some flowers to the reading table.

Comments are closed.